NASDAQ:LGVN
Longeveron Inc. Stock News
$1.54
-0.120 (-7.23%)
At Close: May 09, 2024
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court fo
SHAREHOLDER ALERT: Robbins LLP Announces that Longeveron Inc. (LGVN) is Being Sued for Misleading Shareholders
03:05pm, Friday, 17'th Sep 2021
SAN DIEGO--(BUSINESS WIRE)---- $LGVN #classaction--Longeveron Inc. (LGVN) Materially Misrepresented the Viability of its Lead Product Lomecel-B
NEW YORK, Sept. 17, 2021 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Longeveron Inc. ("Longeveron"
LOS ANGELES, Sept. 16, 2021 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Longeveron Inc. ("Longeveron
New York, New York--(Newsfile Corp. - September 16, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion no la
NEW YORK, Sept. 15, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who
Heart Hope: Announcing the Encouraging Results of a Cell-Therapy Clinical Study by Longeveron
04:08pm, Wednesday, 15'th Sep 2021
Photo by jesse orrico on Unsplash Researchers in the medical field are constantly working to create medicines to prevent and cure diseases. The development of the multiple COVID-19 vaccines from Pfize
LOS ANGELES--(BUSINESS WIRE)---- $LGVN #LGVN--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc.
LOS ANGELES--(BUSINESS WIRE)---- $LGVN #LGVN--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc.
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Longeveron Inc. (NASDAQ:
Pomerantz Law Firm Announces the Filing of a Class Action Against Longeveron Inc. and Certain Officers - LGVN
11:03pm, Monday, 13'th Sep 2021
NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Longeveron Inc. ("Longeveron" or the "Company") (NASDAQ: LGVN) and certain of its o
On the heels of Longeveron's recent announcement showing Lomecel-B significantly increased walking distance in older, frail subjects, Longeveron intends to implement Kinesiometrics new digital data-dr
Longeveron Announces Final Results of Phase 1 Clinical Study of Lomecel-B Injection in Hypoplastic Left Heart Syndrome Patients
08:42am, Thursday, 09'th Sep 2021
--Study meets primary safety endpoint: no major adverse cardiac events (MACE), nor any treatment-related infections during the first month post-treatment. --Secondary endpoints measured per protocol
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Longeveron Inc. - LGVN
06:03pm, Tuesday, 17'th Aug 2021
New York, New York--(Newsfile Corp. - August 17, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Longeveron Inc. ("Longeveron" or the "Company") (NASDAQ: LGVN). Such investors
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Longeveron Inc. - LGVN
05:03pm, Monday, 16'th Aug 2021
NEW YORK, Aug. 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Longeveron Inc. ("Longeveron" or the "Company") (NASDAQ: LGVN). Such investors are advised
